|
Demographics of the study subjects |
||||
| Study Group |
Number |
Age (yr) Median (range) |
Sex (male: female) |
Race |
|
|
||||
| ASD1 |
||||
| Test |
26 |
7.6 (2.3–13.4) |
25:1 |
W2 24, H 1, AA 0, A 1 |
| Control |
107 |
4.8 (1.5–17.3) |
92:15 |
W 77, H 7, AA 11, A 9, other 3 |
|
|
||||
| CRS/ROM |
38 |
6.8 (1.0–17.8) |
27:11 |
W 12, H 16, AA 8, A 2 |
|
|
||||
| FA |
24 |
2.5 (1.0–13.7) |
18:6 |
W 12, H 4, AA 4, A 4 |
|
|
||||
| Control |
43 |
7.0 (1.0–13.8) |
31:12 |
W 31, H 6, AA 3, A 3 |
|
1 ASD test group patients were diagnosed with autism (N = 21), pervasive developmental disorder not otherwise specified (PDD-NOS) (N = 4), and ASD (not categorized as autism or PDD-NOS due to age) (N = 1). ASD control group patients were diagnosed with autism (N = 70), PDD-NOS (N = 27), and ASD (not categorized as autism or PDD-NOS due to age) (N = 10). 2 Abbreviations: W Caucasian, H Hispanic, AA African American, A Asian. | ||||
Jyonouchi et al. Journal of Neuroinflammation 2008 5:52 doi:10.1186/1742-2094-5-52 |
||||